Sunshine Biopharma, Inc. (SBFMW)Fort Lauderdale, United States | NasdaqCM
0.14 USD
Short-term: ☆☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 3:15 p.m. EDT
SBFMW exhibits extremely weak fundamentals with negative profit margins, negative return on assets and equity, and a significant amount of debt. The stock has been trading at a consistent low price for an extended period, suggesting a lack of investor confidence and momentum. There is no indication of dividend payouts, and the recent news does not provide a strong case for long-term growth. This stock is highly speculative and should be avoided unless there is a substantial turnaround in fundamentals or a clear catalyst for value appreciation. |
| Attribute | Value |
|---|---|
| Debt to Equity Ratio | 3.526 |
| Revenue per Share | 8.733 |
| Beta | 1.60 |
| Profit Margins | -16.46% |
| Website | https://sunshinebiopharma.com |
| Attribute | Value |
|---|---|
| Address1 | 333 Las Olas Way |
| Address2 | CU4 Suite 433 |
| Ask | 0.0 |
| Ask Size | 0 |
| Beta | 1.602 |
| Bid | 0.0 |
| Bid Size | 0 |
| Book Value | 4.693 |
| City | Fort Lauderdale |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.139 |
| Current Ratio | 4.167 |
| Custom Price Alert Confidence | HIGH |
| Day High | 0.139 |
| Day Low | 0.139 |
| Debt To Equity | 3.526 |
| Display Name | Sunshine Biopharma |
| Ebitda | -4,146,712 |
| Ebitda Margins | -0.11422 |
| Eps Trailing Twelve Months | -2.214 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Two Week High | 0.139 |
| Fifty Two Week High Change | 0.0 |
| Fifty Two Week High Change Percent | 0.0 |
| Fifty Two Week Low | 0.139 |
| Fifty Two Week Low Change | 0.0 |
| Fifty Two Week Low Change Percent | 0.0 |
| Fifty Two Week Range | 0.139 - 0.139 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,772,807,400,000 |
| Float Shares | 4,803,950 |
| Free Cashflow | -4,632,801 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 50 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.33757 |
| Gross Profits | 12,255,677 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Ipo Expected Date | 2,022-02-15 |
| Language | en-US |
| Long Business Summary | Sunshine Biopharma, Inc. operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates through Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products segments. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida. |
| Long Name | Sunshine Biopharma, Inc. |
| Market | us_market |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_78729055 |
| Net Income To Common | -5,975,352 |
| Open | 0.2428 |
| Operating Cashflow | -5,331,073 |
| Operating Margins | -0.19333 |
| Phone | 954 330 0684 |
| Previous Close | 0.139 |
| Price Hint | 4 |
| Price To Book | 0.029618582 |
| Profit Margins | -0.16458 |
| Quick Ratio | 1.953 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0 |
| Regular Market Change Percent | 0.0 |
| Regular Market Day High | 0.139 |
| Regular Market Day Low | 0.139 |
| Regular Market Day Range | 0.139 - 0.139 |
| Regular Market Open | 0.2428 |
| Regular Market Previous Close | 0.139 |
| Regular Market Price | 0.139 |
| Regular Market Time | 1,776,192,537 |
| Regular Market Volume | 300 |
| Return On Assets | -0.09232 |
| Return On Equity | -0.25679 |
| Revenue Growth | -0.106 |
| Revenue Per Share | 8.733 |
| Sand P52 Week Change | 0.38150132 |
| Sector | |
| Sector Key | |
| Short Name | Sunshine Biopharma Inc. warrant |
| Source Interval | 15 |
| State | FL |
| Symbol | SBFMW |
| Total Cash | 9,123,308 |
| Total Cash Per Share | 1.86 |
| Total Debt | 812,422 |
| Total Revenue | 36,305,892 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.214 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Type Disp | Equity |
| Volume | 300 |
| Website | https://sunshinebiopharma.com |
| Zip | 33,301 |